Company Filing History:
Years Active: 1980-1984
Title: Michael J Dimsdale: Innovator in Pharmaceutical Chemistry
Introduction
Michael J Dimsdale is a notable inventor based in Villebon sur Yvette, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents to his name, Dimsdale's work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Among his latest patents, Dimsdale has developed 1,2,3,4-Tetrahydronaphthalene derivatives. These new compounds are characterized by a specific formula where R1 represents a hydrogen atom or an alkanoyl group containing from 1 to 4 carbon atoms. R2 and R3 can be a hydrogen atom or a C1-C4 alkyl group, while R4 represents a hydroxy or methoxy group in the 6-position or 7-position. These compounds have been found to be useful in therapy, particularly in the treatment of cardiovascular diseases and Parkinson's disease. Another significant patent involves 1,2,4-Oxadiazole derivatives, which are pharmaceutically useful as anti-hypertensive agents. These derivatives are defined by a complex formula that includes various functional groups, showcasing Dimsdale's expertise in creating effective pharmaceutical compounds.
Career Highlights
Michael J Dimsdale is currently associated with Synthelabo, a company known for its focus on pharmaceutical innovations. His work at Synthelabo has allowed him to explore and develop new therapeutic agents that address critical health issues. Dimsdale's contributions to the field have been recognized for their potential impact on patient care and treatment outcomes.
Collaborations
Throughout his career, Dimsdale has collaborated with esteemed colleagues, including Nigel R Beeley and Gerard Cremer. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical products.
Conclusion
Michael J Dimsdale stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing innovative compounds for therapeutic use. His patents reflect a commitment to advancing medical science and improving patient health outcomes.